Table of Contents
ISRN Cardiology
Volume 2013, Article ID 731285, 7 pages
http://dx.doi.org/10.1155/2013/731285
Review Article

Diagnosis and Treatment of Asymptomatic Left Ventricular Systolic Dysfunction after Myocardial Infarction

Chair and Division of Cardiology, Policlinico Universitario “Paolo Giaccone”, Palermo, Italy

Received 13 January 2013; Accepted 30 January 2013

Academic Editors: W. S. Aronow, W. Bloch, T. Shimada, and Z.-M. Zhang

Copyright © 2013 Laura Ajello et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Rosamond, K. Flegal, K. Furie et al., “Heart disease and stroke statistics-2008 Update: a report from the American heart association statistics committee and stroke statistics subcommittee,” Circulation, vol. 117, no. 4, pp. e25–e46, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Køber, C. Torp-Pedersen, S. Jørgensen, P. Eliasen, and A. J. Camm, “Changes in absolute and relative importance in the prognostic value of left ventricular systolic function and congestive heart failure after acute myocardial infarction,” American Journal of Cardiology, vol. 81, no. 11, pp. 1292–1297, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. ACC/AHA, “Guidelines update for the diagnosis and managenment of chronic heart failure in the adult,” Journal of the American College of Cardiology, vol. 53, pp. 1343–1382, 2009. View at Google Scholar
  4. M. Gheorghiade and R. O. Bonow, “Chronic heart failure in the United States: a manifestation of coronary artery disease,” Circulation, vol. 97, no. 3, pp. 282–289, 1998. View at Google Scholar · View at Scopus
  5. C. G. Frazier, K. P. Alexander, L. K. Newby et al., “Association of gender and etiology with outcomes in heart failure with systolic dysfunction,” Journal of the American College of Cardiology, vol. 49, no. 13, pp. 1450–1458, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. L. M. Mielniczuk, G. A. Lamas, G. C. Flaker et al., “Left ventricular end-diastolic pressure and risk of subsequent heart failure in patients following an acute myocardial infarction,” Congestive Heart Failure, vol. 13, no. 4, pp. 209–214, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. J. G. F. Cleland, A. Torabi, and N. K. Khan, “Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction,” Heart, vol. 91, supplement 2, pp. ii7–ii13, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J. P. Hellermann, S. J. Jacobsen, B. J. Gersh, R. J. Rodeheffer, G. S. Reeder, and V. L. Roger, “Heart failure after myocardial infarction: a review,” American Journal of Medicine, vol. 113, no. 4, pp. 324–330, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Køber, C. Torp-Pedersen, J. E. Carlsen et al., “A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction,” The New England Journal of Medicine, vol. 333, no. 25, pp. 1670–1676, 1995. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Giannuzzi, P. L. Temporelli, E. Bosimini et al., “Heterogeneity of left ventricular remodeling after acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-3 Echo Substudy,” American Heart Journal, vol. 141, no. 1, pp. 131–138, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Bosimini, P. Giannuzzi, P. L. Temporelli et al., “Electrocardiographic evolutionary changes and left ventricular remodeling after acute myocardial infarction: results of the GISSI-3 Echo substudy,” Journal of the American College of Cardiology, vol. 35, no. 1, pp. 127–135, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Hasdai, E. J. Topoi, R. Kilaru et al., “Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials,” American Heart Journal, vol. 145, no. 1, pp. 73–79, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. P. G. Steg, O. H. Dabbous, L. J. Feldman et al., “Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observation from GRACE,” Circulation, vol. 109, no. 4, pp. 494–499, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Pfeffer, E. Braunwald, L. A. Moye et al., “Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction—results of the survival and ventricular enlargement trial,” The New England Journal of Medicine, vol. 327, no. 10, pp. 669–677, 1992. View at Google Scholar · View at Scopus
  15. S. D. Solomon, S. Zelenkofske, J. J. V. McMurray et al., “Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both,” The New England Journal of Medicine, vol. 352, no. 25, pp. 2581–2588, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. D. L. Mann and M. R. Bristow, “Mechanisms and models in heart failure: the biomechanical model and beyond,” Circulation, vol. 111, no. 21, pp. 2837–2849, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Pitt, W. Remme, F. Zannad et al., “Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction,” The New England Journal of Medicine, vol. 348, no. 14, pp. 1309–1321, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. H. J. Dargie, “Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomised trial,” The Lancet, vol. 357, no. 9266, pp. 1385–1390, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. T. J. Wang, J. C. Evans, E. J. Benjamin, D. Levy, E. C. LeRoy, and R. S. Vasan, “Natural history of asymptomatic left ventricular systolic dysfunction in the community,” Circulation, vol. 108, no. 8, pp. 977–982, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. ACC/AHA, “ACC/AHA 2008 performance measures for adults With ST-elevation and non–ST-elevation myocardial infarction,” Circulation, vol. 118, pp. 2596–2648, 2008. View at Google Scholar
  21. The SOLVD Investigators, “Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions,” The New England Journal of Medicine, vol. 327, no. 10, pp. 685–691, 1992. View at Google Scholar
  22. P. Jong, S. Yusuf, M. F. Rousseau, S. A. Ahn, and S. I. Bangdiwala, “Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study,” The Lancet, vol. 361, no. 9372, pp. 1843–1848, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. The SOLVD Investigators, “Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure,” The New England Journal of Medicine, vol. 325, no. 5, pp. 293–302, 1991. View at Google Scholar · View at Scopus
  24. J. G. Crilley and M. Farrer, “Left ventricular remodelling and brain natriuretic peptide after first myocardial infarction,” Heart, vol. 86, no. 6, pp. 638–642, 2001. View at Google Scholar · View at Scopus
  25. P. Bettencourt, A. Ferreira, N. Pardal-Oliveira et al., “Clinical significance of brain natriuretic peptide in patients with postmyocardial infarction,” Clinical Cardiology, vol. 23, no. 12, pp. 921–927, 2000. View at Google Scholar · View at Scopus
  26. G. F. Mitchell, G. A. Lamas, D. E. Vaughan, and M. A. Pfeffer, “Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape,” Journal of the American College of Cardiology, vol. 19, no. 6, pp. 1136–1144, 1992. View at Google Scholar · View at Scopus
  27. G. A. lamas, D. E. Vaughan, A. F. Parisi, and M. A. Pfeffer, “Effects of left ventricular shape and captopril therapy on exercise capacity after anterior wall acute myocardial infarction,” American Journal of Cardiology, vol. 63, no. 17, pp. 1167–1173, 1989. View at Google Scholar · View at Scopus
  28. N. Sharpe, H. Smith, J. Murphy, S. Greaves, H. Hart, and G. Gamble, “Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition,” The Lancet, vol. 337, no. 8746, pp. 872–876, 1991. View at Publisher · View at Google Scholar · View at Scopus
  29. R. N. Doughty, G. A. Whalley, G. Gamble, S. MacMahon, and N. Sharpe, “Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease,” Journal of the American College of Cardiology, vol. 29, no. 5, pp. 1060–1066, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Vantrimpont, J. L. Rouleau, C. C. Wun et al., “Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) study,” Journal of the American College of Cardiology, vol. 29, no. 2, pp. 229–236, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. D. V. Exner, D. L. Dries, M. A. Waclawiw, B. Shelton, and M. Domanski, “Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction,” Journal of the American College of Cardiology, vol. 33, no. 4, pp. 916–923, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Ambrosioni, C. Borhi, and B. Magnani, “The effect of the ACE inhibitor zofenopril on mortality and morbility after anteriormyocardial infarction. The SMILE Study Investigators,” The New England Journal of Medicine, vol. 332, pp. 1715–1716, 1995. View at Google Scholar
  33. P. J. de Kam, A. A. Voors, M. P. Van Den Berg et al., “Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: results of a meta-analysis of 845 patients,” Journal of the American College of Cardiology, vol. 36, no. 7, pp. 2047–2053, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. Heart Failure Society of America, “Executive summary: HFSA 2010 comprehensive heart failure practice guideline,” Journal of Cardiac Failure, vol. 16, no. 6, pp. 475–539, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. W. S. Colucci, T. J. Kolias, K. F. Adams et al., “Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: The REversal of VEntricular Remodeling with Toprol-XL (REVERT) Trial,” Circulation, vol. 116, no. 1, pp. 49–56, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. M. G. Shlipak, W. S. Browner, H. Noguchi, B. Massie, C. D. Frances, and M. McClellan, “Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction,” American Journal of Medicine, vol. 110, no. 6, pp. 425–433, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Garg, R. Gorlin, T. Smith, and S. Yusuf, “The effect of digoxin on mortality and morbidity in patients with heart failure,” The New England Journal of Medicine, vol. 336, no. 8, pp. 525–533, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. S. S. Rathore, Y. Wang, and H. M. Krumholz, “Sex-based differences in the effect of digoxin for the treatment of heart failure,” The New England Journal of Medicine, vol. 347, no. 18, pp. 1403–1411, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Fox, I. Ford, P. G. Steg, M. Tendera, and R. Ferrari, “Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial,” The Lancet, vol. 372, no. 9641, pp. 807–816, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. A. E. Buxton, K. L. Lee, J. D. Fisher, M. E. Josephson, E. N. Prystowsky, and G. Hafley, “A randomized study of the prevention of sudden death in patients with coronary artery disease,” The New England Journal of Medicine, vol. 341, no. 25, pp. 1882–1890, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. A. J. Moss, W. Zareba, W. Jackson Hall et al., “Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction,” The New England Journal of Medicine, vol. 346, no. 12, pp. 877–883, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. S. H. Hohnloser, K. H. Kuck, P. Dorian et al., “Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction,” The New England Journal of Medicine, vol. 351, no. 24, pp. 2481–2488, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Van de Werf, J. Bax, A. Betriu et al., “Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation,” European Heart Journal, vol. 29, pp. 2909–2945, 2008. View at Google Scholar
  44. A. J. Moss, W. J. Hall, D. S. Cannom et al., “Cardiac-resynchronization therapy for the prevention of heart-failure events,” The New England Journal of Medicine, vol. 361, no. 14, pp. 1329–1338, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. ESC Guidelines 201, “Focused update on device therapy in heart failure,” European Heart Journal, vol. 31, pp. 2677–2687, 2010. View at Google Scholar
  46. F. A. Spencer, T. E. Meyer, J. M. Gore, and R. J. Goldberg, “Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the national registry of myocardial infarction,” Circulation, vol. 105, no. 22, pp. 2605–2610, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. W. B. Kannel, “Lessons from curbing the coronary artery disease epidemic for confronting the impending epidemic of heart failure,” Medical Clinics of North America, vol. 88, no. 5, pp. 1129–1133, 2004. View at Publisher · View at Google Scholar · View at Scopus